Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret
about
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesSingle-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 virusesIntranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challengeBroadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection.Adenoviral vectors as novel vaccines for influenza.Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.Pseudotype-based neutralization assays for influenza: a systematic analysis.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininDesign and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.Viral vector-based influenza vaccines.Cross-protective immunity to influenza A viruses.Development of adenoviral vector-based mucosal vaccine against influenza.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.New technologies for influenza vaccines.Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.Immunobiology of influenza vaccinesFusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virusIntranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.Virus-vectored influenza virus vaccines.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinNew Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza virusesInduction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response.Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.Progress on adenovirus-vectored universal influenza vaccines.Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice.Employing XIAP to enhance the duration of antigen expression and immunity against an avian influenza H5 DNA vaccine.Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.Towards a universal influenza vaccine: different approaches for one goal.Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.
P2860
Q27013568-BBA6BBAA-7EC5-47A5-B5E9-9A9C4B860E47Q27318575-A32F7AF9-DE60-42AC-B2AF-4F715701F041Q27345256-3711A1E4-43D2-4828-B557-3AF35FEBCF47Q30223058-1AF5B925-5A27-4C2A-89B8-3B194D2B4957Q30226988-E96C89CC-4A7F-4EC5-8718-DEE6DF48760FQ30362529-4DFCEDB9-D289-4D1A-85F2-FFCF7148BBF7Q30370445-9DEABA2D-FAC2-415D-AB99-25CE13DDE038Q30373963-85C08225-912C-4CD3-A8F0-18FF479D225EQ30374662-569F4A1C-5149-4D49-8951-53480C6EE447Q30376724-8BEB09F6-D9A6-4E26-A0AF-F36C2306CCF3Q30380290-207FA493-23C2-4CFB-80DB-43401AE6631EQ30384878-9C1161CB-92A7-4B11-A043-23BAB5A2E0F2Q30390938-417B9BF1-D8A3-4312-B9CF-9B9D39D40862Q30396399-FE78CA41-3AA4-467F-8025-C456F8283038Q30396642-56C069E5-E053-4D9F-AC6B-C1DCA2E37ADBQ30403507-1E11C3AE-204E-48CD-A3AD-7D091538D109Q30407424-D67DF557-F491-4A17-A729-65DD360812B3Q30410241-76A12421-82CD-4D7E-96EB-A4325FEFBEA5Q30411859-A88713DD-C35A-4870-AA02-1AD163E88344Q30418612-2EC6D022-1131-46D5-A36E-1A8FDB5169C3Q30426771-AE4905C4-F086-4D96-996B-F9FC9EA4732BQ33920103-49BBEE6E-C353-4255-89C7-4F16EB47E0A2Q34059627-D84403E4-458A-4D66-A93B-37502883A756Q34102268-2786E256-98EC-4A4D-B367-95ECB5961C36Q34105207-4F2FCA37-670C-4F2A-97F1-FCA58F86AF4CQ34629573-A6F85361-11AF-41E8-8548-17A028EE4624Q35078213-44CF7E0B-5A66-43F0-ABA4-8131CDB37D42Q35575511-3063BB7A-5EF5-4668-986C-69F8E6519453Q35780387-5DCF98EC-7819-437E-97CB-D56CC6C54AB0Q35921308-194F2AF4-3EEC-4EDD-ADCB-0A2B5544A8CEQ36437406-3171E5DE-BEA2-4465-AE73-600F9C37AD24Q37570525-F5067961-82D7-4F87-B0BA-7E85C0FDF791Q37866816-030CE693-BDF7-4E4F-8E21-EDF5078880CDQ38421971-55293397-6146-40D0-BA1A-7A878F368A2EQ38822536-2859E962-FD92-49C8-B532-80D9B03C5EB2Q40076766-348211D1-E7B5-414E-8B05-94664115E232Q41363923-9E19787C-1A46-447C-B38B-4F9496549FBEQ45324179-ABC24D85-C35D-4936-9BA8-DD6ACAAA6DC7Q47548866-EEBBD5EF-6D59-42E9-B585-AE67EDCD3802Q49829189-A3CFEDDE-629F-4A33-AF94-D8B63F4AADD6
P2860
Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@ast
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@en
Comparative efficacy of hemagg ...... influenza in mouse and ferret.
@nl
type
label
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@ast
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@en
Comparative efficacy of hemagg ...... influenza in mouse and ferret.
@nl
prefLabel
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@ast
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@en
Comparative efficacy of hemagg ...... influenza in mouse and ferret.
@nl
P2093
P2860
P1433
P1476
Comparative efficacy of hemagg ...... influenza in mouse and ferret
@en
P2093
Chih-Jen Wei
Hanne Andersen
J Patrick Gorres
Martha Nason
Neal Van Hoeven
Srinivas S Rao
Wing-Pui Kong
P2860
P356
10.1371/JOURNAL.PONE.0009812
P407
P577
2010-03-23T00:00:00Z